Camp4 Therapeutics Corp - CAMP
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Mar 11, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Vivo Opportunity Fund Holdings, L.P. | 7.4% | 3,856,991 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Vivo Opportunity, LLC | 7.4% | 3,856,991 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Vivo Opportunity Cayman Fund, L.P. | 0.8% | 389,577 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Vivo Opportunity Cayman, LLC | 0.8% | 389,577 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | FMR LLC | 9.5% | 4,918,243 | View |
| Feb 05, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 9.5% | 4,918,243 | View |
| Jan 08, 2026 | SCHEDULE 13G | JANUS HENDERSON GROUP PLC | 12.2% | 6,307,636 | View |
| Dec 23, 2025 | SCHEDULE 13D/A | — | — | — | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Coastlands Capital LP | 9.99% | 4,886,722 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Coastlands Capital Partners LP | 9.99% | 4,886,722 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Coastlands Capital GP LLC | 9.99% | 4,886,722 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Coastlands Capital LLC | 9.99% | 4,886,722 | View |
| Dec 11, 2025 | SCHEDULE 13G/A | Matthew D. Perry | 9.99% | 4,886,722 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | AH Bio Fund I, L.P. | 3.4% | 1,579,885 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | AH Equity Partners Bio I, L.L.C. | 3.4% | 1,579,885 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | AH Bio Fund IV, L.P. | 1.2% | 545,454 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | AH Equity Partners Bio IV, L.L.C. | 1.2% | 545,454 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Marc L. Andreessen | 4.5% | 2,125,339 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Benjamin A. Horowitz | 4.5% | 2,125,339 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Northpond Ventures II, LP | 2.1% | 1,003,193 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Northpond Ventures II GP, LLC | 2.1% | 1,003,193 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Northpond Ventures III, LP | 1.6% | 763,636 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Northpond Ventures III GP, LLC | 1.6% | 0 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Northpond Ventures, LP | 1.0% | 471,415 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Northpond Ventures GP, LLC | 1.0% | 471,415 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Michael P. Rubin | 4.8% | 2,238,244 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | FMR LLC | 6.7% | 3,145,663 | View |
| Nov 07, 2025 | SCHEDULE 13G/A | Abigail P. Johnson | 6.7% | 3,145,663 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.